| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2001;38:827.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
Improved Hypertension Management and Control
Results From the Health Survey for England 1998
From the Royal Free and University College Medical School (P.P., M.B.), London, UK; and Imperial College School of Medicine (N.R.P.), London, UK.
Correspondence to Dr Paola Primatesta, Department of Epidemiology and Public Health, Royal Free and University College Medical School, University College London, Gower St Campus, 1-19 Torrington Place, London, UK WC1E 6BT. E-mail paolap{at}public-health.ucl.ac.uk
Abstract—— A survey in 1994 showed that among the 20% of the adult English population who were identified as hypertensive, 
30% had their blood pressures controlled to <160 mm Hg systolic and <95 mm Hg diastolic. The 1998 Health Survey for England data update the 1994 findings in light of new thresholds and targets for treatment outlined in recent national and international guidelines. This cross-sectional survey is analyzed to describe the prevalence, awareness, treatment, and control of hypertension in a random, nationally representative sample of 11 529 English adults (
16 years) living in noninstitutional households in 1998 and to compare these rates with those from 1994. In 1998, 20% and 37% of adults were hypertensive according to the old (systolic 160 mm Hg or diastolic 95 mm Hg) and new (systolic 140 mm Hg or diastolic 90 mm Hg) definitions, respectively. Corresponding values in 1994 were 20% and 38%. Treatment and control rates among hypertensive adults (new definition) improved from 26% to 32% and from 6% to 9%, respectively, although 60% of those on treatment received only 1 antihypertensive drug in both years. Among persons with controlled hypertension, 59% reported having received nonpharmacological advice from their physicians in 1998 compared with 30% in 1994. Rates of hypertension treatment and control have increased significantly (P=0.05 and P<0.01, respectively) since 1994 but remain low by international standards. The 1998 data suggest that improved detection, greater use of nonpharmacological measures, and increased use of >1 antihypertensive agent per patient would produce greater success in achieving target levels. This could lead to major reductions in fatal and nonfatal cardiovascular events.
Key Words: population • hypertension, detection and control • antihypertensive therapy
This article has been cited by other articles:
 |
|
 |
|
  E. Falaschetti, M. Chaudhury, J. Mindell, and N. Poulter Continued Improvement in Hypertension Management in England: Results From the Health Survey for England 2006 Hypertension, March 1, 2009; 53(3): 480 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mohan and N. R.C. Campbell Hypertension Management: Time to Shift Gears and Scale Up National Efforts Hypertension, March 1, 2009; 53(3): 450 - 451. [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Kjeldsen, T. A. Aksnes, R. H. Fagard, and G. Mancia CHAPTER 13 Hypertension ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Poulter Selecting a fixed combination to improve morbidity/mortality: the weight of evidence with ASCOT Eur. Heart J. Suppl., September 1, 2008; 10(suppl_G): G21 - G28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E Clark, J. L Campbell, R. J Powell, and J. F Thompson The inter-arm blood pressure difference and peripheral vascular disease: cross-sectional study Fam. Pract., October 1, 2007; 24(5): 420 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. He and G. A. MacGregor Blood pressure is the most important cause of death and disability in the world Eur. Heart J. Suppl., May 1, 2007; 9(suppl_B): B23 - B28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. R. Wang, G. C. Alexander, and R. S. Stafford Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States Arch Intern Med, January 22, 2007; 167(2): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mancia Effective Ambulatory Blood Pressure Control in Medical Practice: Good News To Be Taken With Caution Hypertension, January 1, 2007; 49(1): 17 - 18. [Full Text] [PDF]
|
|
|
|
|
|
J. Onysko, C. Maxwell, M. Eliasziw, J. X. Zhang, H. Johansen, N. R.C. Campbell, and for the Canadian Hypertension Education Program Large Increases in Hypertension Diagnosis and Treatment in Canada After a Healthcare Professional Education Program Hypertension, November 1, 2006; 48(5): 853 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R.C. Campbell, K. Tu, R. Brant, M. Duong-Hua, F. A. McAlister, and for the Canadian Hypertension Education Program Ou The Impact of the Canadian Hypertension Education Program on Antihypertensive Prescribing Trends Hypertension, January 1, 2006; 47(1): 22 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Tobin, S. M. Raleigh, S. Newhouse, P. Braund, C. Bodycote, J. Ogleby, D. Cross, J. Gracey, S. Hayes, T. Smith, et al. Association of WNK1 Gene Polymorphisms and Haplotypes With Ambulatory Blood Pressure in the General Population Circulation, November 29, 2005; 112(22): 3423 - 3429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Amato Jr., L. Fauchier, D. Babuty, E. K. Heist, J. W. Harthorne, J. P. Singh, W. D. Toff, A. J. Camm, J. D. Skehan, and the UKPACE Trial Investigators Pacing for atrioventricular block. N. Engl. J. Med., October 20, 2005; 353(16): 1742 - 1744. [Full Text] [PDF]
|
|
|
|
|
|
C. M. McEniery, Yasmin, S. Wallace, K. Maki-Petaja, B. McDonnell, J. E. Sharman, C. Retallick, S. S. Franklin, M. J. Brown, R. C. Lloyd, et al. Increased Stroke Volume and Aortic Stiffness Contribute to Isolated Systolic Hypertension in Young Adults Hypertension, July 1, 2005; 46(1): 221 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Primatesta Guidelines and risk factor management Heart, April 1, 2005; 91(4): 417 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kirby Has ASCOT signalled the end for beta blockers as first-line antihypertensive agents? The British Journal of Diabetes & Vascular Disease, March 1, 2005; 5(2): 100 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Psaltopoulou, P. Orfanos, A. Naska, D. Lenas, D. Trichopoulos, and A. Trichopoulou Prevalence, awareness, treatment and control of hypertension in a general population sample of 26 913 adults in the Greek EPIC study Int. J. Epidemiol., December 1, 2004; 33(6): 1345 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. P Cappuccio, S. M Kerry, L. Forbes, and A. Donald Blood pressure control by home monitoring: meta-analysis of randomised trials BMJ, July 17, 2004; 329(7458): 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F D R Hobbs Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia Heart, June 1, 2004; 90(suppl_4): iv22 - iv25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A McKerracher Treating to hypertension targets Heart, June 1, 2004; 90(suppl_4): iv33 - iv35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Williams, N. R Poulter, M. J Brown, M. Davis, G. T McInnes, J. F Potter, P. S Sever, and S. M. Thom British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary BMJ, March 13, 2004; 328(7440): 634 - 640. [Full Text] [PDF]
|
|
|
|
|
|
K. Wolf-Maier, R. S. Cooper, H. Kramer, J. R. Banegas, S. Giampaoli, M. R. Joffres, N. Poulter, P. Primatesta, B. Stegmayr, and M. Thamm Hypertension Treatment and Control in Five European Countries, Canada, and the United States Hypertension, January 1, 2004; 43(1): 10 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Borzecki, A. T. Wong, E. C. Hickey, A. S. Ash, and D. R. Berlowitz Hypertension Control: How Well Are We Doing? Arch Intern Med, December 8, 2003; 163(22): 2705 - 2711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Williams Treatment of hypertension in the UK: simple as ABCD? J R Soc Med, November 1, 2003; 96(11): 521 - 522. [Full Text] [PDF]
|
|
|
|
|
|
T. Walley, A. K Duggan, A. R Haycox, and C. J Niziol Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK J R Soc Med, November 1, 2003; 96(11): 525 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wolf-Maier, R. S. Cooper, J. R. Banegas, S. Giampaoli, H.-W. Hense, M. Joffres, M. Kastarinen, N. Poulter, P. Primatesta, F. Rodriguez-Artalejo, et al. Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States JAMA, May 14, 2003; 289(18): 2363 - 2369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gu, K. Reynolds, X. Wu, J. Chen, X. Duan, P. Muntner, G. Huang, R. F. Reynolds, S. Su, P. K. Whelton, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in China Hypertension, December 1, 2002; 40(6): 920 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P Cappuccio, P. Oakeshott, P. Strazzullo, and S. M Kerry Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study BMJ, November 30, 2002; 325(7375): 1271 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gupta, S. Gupta, and J. D. Cohen Undertreatment of Hypertension: A Dozen Reasons Arch Intern Med, October 28, 2002; 162(19): 2246 - 2248. [Full Text] [PDF]
|
|
|
|
 |
|
 H. W. Hense, W. Maziak, and J. Heidrich Why is blood pressure control unsatisfactory--or is it? Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1547 - 1550. [Full Text] [PDF]
|
|